Tag Archives: janssen pharmaceuticals

Featured Stories

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Pradaxa Associated with more Complications than Warfarin, According to Early Study Findings

Early results from the largest study to date to compare Pradaxa and warfarin indicate that in a real-world setting, Pradaxa causes more complications than decades-old warfarin. The preliminary study results were announced last week, during the 2012 Thrombosis and Hemostasis Summit of North America.

Read More

Western Pennsylvania Familes File Suit Over Alleged Fracking Pollution

Three families in western Pennsylvania believe a leading hydraulic fracturing (fracking) company and two water testing labs are conspiring to produce false results that show natural gas drilling is not contaminating their private water wells.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

Jurors Told that J&J Obscured Risperdal Gynecomastia Data

A number of lawsuits have been filed over Risperdal, an antipsychotic medication marketed by Johnson & Johnson’s Janssen Pharmaceuticals. Plaintiffs allege that the drug caused gynecomastia, or abnormal breast growth, in adolescent boys. The suits allege that J&J knew about … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

Xarelto Plaintiffs Hope for Outcome Similar to Pradaxa Settlement

Xarelto Plaintiffs Hope for Similar Pradaxa Settlement

The current multidistrict litigation (MDL) comprised of more than 7,000 Xarelto (rivoxaban) lawsuits filed against the Johnson & Johnson subsidiary, Janssen Pharmaceuticals, and Bayer AG is being overseen by the Honorable Judge Eldon E. Fallon in the Eastern District of … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , , , , , |

In Xarelto MDL, Judge Extends Deadline to File Complaints

In Xarelto MDL, Judge Extends Deadline to File Complaints

Certain groups of plaintiffs in the Xarelto multidistrict litigation (MDL) have more time to file a lawsuit against manufacturers Janssen Pharmaceuticals and Bayer Healthcare. According to a recent order issued by Judge Eldon Fallon, who is overseeing the MDL in … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , |

New York Woman Files Levaquin Peripheral Neuropathy Lawsuit

New York Woman Files Levaquin Peripheral Neuropathy Lawsuit

A new lawsuit was filed against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals on behalf of a New York woman who alleges that the antibiotic Levaquin caused peripheral neuropathy. She alleges that the drug makers failed to warn her … Continue reading

Posted in Levaquin, Pharmaceuticals | Tagged , , , , , , |

Quality of Xarelto Clinical Trials Expected to be an Issue in 2017 Court Cases

Xarelto Clinical Trials to be an Issue in 2017 Lawsuits

When the first lawsuits involving the blood-thinning drug Xarelto go to trial in 2017, attorneys expect the quality of the clinical trials involved in the drug’s approval to be a major issue. Xarelto lawsuits have been filed in both federal … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , , |

$70 Million Awarded in Risperdal Gynecomastia Lawsuit

$70 Million Awarded in Risperdal Gynecomastia Lawsuit

An attempt was made by Johnson & Johnson (J&J) to overturn the largest award seen to date in a $70 million Risperdal gynecomastia verdict. The Pennsylvania judge presiding over the matter refused the request made by the manufacturer of J&J’s … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , , , , , , , |

Lawsuits Against Levaquin Claim It Causes Peripheral Neuropathy

Levaquin Suits Allege The Drug Causes Peripheral Neuropathy

Johnson & Johnson faces a new wave of lawsuits in federal court in New Jersey alleging its antibiotic Levaquin caused nerve damage. From August 1 to 11, 13 Levaquin suits with 18 plaintiffs were filed against Johnson & Johnson and … Continue reading

Posted in Cipro, Levaquin, Pharmaceuticals | Tagged , , , , , , , , |

Xarelto Lawsuits Continue to Mount, Clinical Trials Under Scrutiny

Xarelto Lawsuits Rise, Clinical Trials Under Scrutiny

According to court records, Bayer AG and Janssen Pharmaceuticals are facing close to 6,000 lawsuits alleging that the companies failed to warn about the risks associated with Xarelto, an anti-coagulant drug. Plaintiffs in the litigation allege that the blood thinner … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , |

Xarelto Lawsuits Have Added Credibility Based on Scholarly Studies

Xarelto Cases Added Credibility Based on Scholarly Studies

The makers of Xarelto, an anticoagulant that was credited as a breakthrough in blood clot prevention, is battling numerous lawsuits. An alleged connection between an elevated risk for serious hemorrhages and Xarelto are now being lent possible increased credibility through … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , , , |

© 2005-2019 Parker Waichman LLP ®. All Rights Reserved.